Medical device company Penumbra (NYSE:PEN) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up ...
StockStory.org on MSN5d
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of EarningsMedical device company Penumbra (NYSE:PEN) will be reporting earnings tomorrow afternoon. Here’s what you need to know.
On a per-share basis, the Alameda, California-based company said it had net income of 86 cents. Earnings, adjusted for non-recurring costs, came to 97 cents per share. The results beat Wall Street ...
Penumbra, Inc. (NYSE:PEN – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday following a better than expected earnings announcement. The company traded as high as $304.
Penumbra (PEN) came out with quarterly earnings ... A quarter ago, it was expected that this medical device maker would post earnings of $0.69 per share when it actually produced earnings of ...
Penumbra (NYSE:PEN – Free Report) had its price objective increased by Robert W. Baird from $305.00 to $328.00 in a report ...
(AP) — Penumbra Inc. (PEN ... by Zacks Investment Research was for earnings of 91 cents per share. The medical device maker posted revenue of $315.5 million in the period, also surpassing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results